Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Thorsten Stiewe

Showing results (51-60 of 167) with videos related to

Pageof 17
Sort By:
Hemasphere|May 6, 2022
The Nuclear Proteins TP73 and CUL4A Confer Resistance to Cytarabine by Induction of Translesion DNA Synthesis via Mono-ubiquitination of PCNAMiriam Rehberger, Jonas A Schäfer, Anna-Maria Krampitz, et al.
International Journal of Molecular Sciences|February 10, 2021
C1q/TNF-Related Protein 3 (CTRP-3) Deficiency of Adipocytes Affects White Adipose Tissue Mass but Not Systemic CTRP-3 ConcentrationsAndreas Schmid, Martin Roderfeld, Jonas Gehl, et al.
Nucleic Acids Research|February 13, 2008
C-terminal diversity within the p53 family accounts for differences in DNA binding and transcriptional activityMarkus Sauer, Anne Catherine Bretz, Rasa Beinoraviciute-Kellner, et al.
Cell Reports|May 14, 2013
p53 DNA binding cooperativity is essential for apoptosis and tumor suppression in vivoOleg Timofeev, Katharina Schlereth, Michael Wanzel, et al.
Oncogene|December 15, 2021
p53 partial loss-of-function mutations sensitize to chemotherapyBoris Klimovich, Nastasja Merle, Michelle Neumann, et al.
Molecular Carcinogenesis|December 31, 2013
The pan-deacetylase inhibitor panobinostat suppresses the expression of oncogenic miRNAs in hepatocellular carcinoma cell linesAlexander Henrici, Roberta Montalbano, Daniel Neureiter, et al.
Leukemia & Lymphoma|February 11, 2015
Sorafenib induces paradoxical phosphorylation of the extracellular signal-regulated kinase pathway in acute myeloid leukemia cells lacking FLT3-ITD mutationFariba Fouladi, Lutz B Jehn, Stephan K Metzelder, et al.
Journal of Experimental & Clinical Cancer Research : CR|August 10, 2023
Mutant p53-ENTPD5 control of the calnexin/calreticulin cycle: a druggable target for inhibiting integrin-α5-driven metastasisEvangelos Pavlakis, Michelle Neumann, Nastasja Merle, et al.
Nucleic Acids Research|July 18, 2022
Notch-dependent and -independent functions of transcription factor RBPJTobias Friedrich, Francesca Ferrante, Léo Pioger, et al.
Cancers|October 13, 2021
Superior Overall Survival in Patients with Colorectal Cancer, Regular Aspirin Use, and Combined Wild-Type PIK3CA and KRAS-Mutated TumorsLeonie Gebauer, Andrea Nist, Marco Mernberger, et al.
Pageof 17

Showing results (51-60 of 167) with videos related to

Sort By:
Pageof 17
Hemasphere|May 6, 2022
The Nuclear Proteins TP73 and CUL4A Confer Resistance to Cytarabine by Induction of Translesion DNA Synthesis via Mono-ubiquitination of PCNAMiriam Rehberger, Jonas A Schäfer, Anna-Maria Krampitz, et al.
International Journal of Molecular Sciences|February 10, 2021
C1q/TNF-Related Protein 3 (CTRP-3) Deficiency of Adipocytes Affects White Adipose Tissue Mass but Not Systemic CTRP-3 ConcentrationsAndreas Schmid, Martin Roderfeld, Jonas Gehl, et al.
Nucleic Acids Research|February 13, 2008
C-terminal diversity within the p53 family accounts for differences in DNA binding and transcriptional activityMarkus Sauer, Anne Catherine Bretz, Rasa Beinoraviciute-Kellner, et al.
Cell Reports|May 14, 2013
p53 DNA binding cooperativity is essential for apoptosis and tumor suppression in vivoOleg Timofeev, Katharina Schlereth, Michael Wanzel, et al.
Oncogene|December 15, 2021
p53 partial loss-of-function mutations sensitize to chemotherapyBoris Klimovich, Nastasja Merle, Michelle Neumann, et al.
Molecular Carcinogenesis|December 31, 2013
The pan-deacetylase inhibitor panobinostat suppresses the expression of oncogenic miRNAs in hepatocellular carcinoma cell linesAlexander Henrici, Roberta Montalbano, Daniel Neureiter, et al.
Leukemia & Lymphoma|February 11, 2015
Sorafenib induces paradoxical phosphorylation of the extracellular signal-regulated kinase pathway in acute myeloid leukemia cells lacking FLT3-ITD mutationFariba Fouladi, Lutz B Jehn, Stephan K Metzelder, et al.
Journal of Experimental & Clinical Cancer Research : CR|August 10, 2023
Mutant p53-ENTPD5 control of the calnexin/calreticulin cycle: a druggable target for inhibiting integrin-α5-driven metastasisEvangelos Pavlakis, Michelle Neumann, Nastasja Merle, et al.
Nucleic Acids Research|July 18, 2022
Notch-dependent and -independent functions of transcription factor RBPJTobias Friedrich, Francesca Ferrante, Léo Pioger, et al.
Cancers|October 13, 2021
Superior Overall Survival in Patients with Colorectal Cancer, Regular Aspirin Use, and Combined Wild-Type PIK3CA and KRAS-Mutated TumorsLeonie Gebauer, Andrea Nist, Marco Mernberger, et al.
Pageof 17